- Home
- BLFS vs CDNA Comparison
BLFS vs CDNA Comparison
Compare BLFS & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLFS
- CDNA
- Stock Information
- Founded
- BLFS 1987
- CDNA 1998
- Country
- BLFS United States
- CDNA United States
- Employees
- BLFS N/A
- CDNA N/A
- Industry
- BLFS Medical/Dental Instruments
- CDNA Medical Specialities
- Sector
- BLFS Health Care
- CDNA Health Care
- Exchange
- BLFS Nasdaq
- CDNA Nasdaq
- Market Cap
- BLFS 1.2B
- CDNA 1.1B
- IPO Year
- BLFS 1989
- CDNA 2014
- Fundamental
- Price
- BLFS $21.91
- CDNA $17.62
- Analyst Decision
- BLFS Strong Buy
- CDNA Buy
- Analyst Count
- BLFS 7
- CDNA 8
- Target Price
- BLFS $30.57
- CDNA $28.14
- AVG Volume (30 Days)
- BLFS 612.2K
- CDNA 681.4K
- Earning Date
- BLFS 05-08-2025
- CDNA 04-30-2025
- Dividend Yield
- BLFS N/A
- CDNA N/A
- EPS Growth
- BLFS N/A
- CDNA N/A
- EPS
- BLFS N/A
- CDNA 0.93
- Revenue
- BLFS $82,254,000.00
- CDNA $333,785,000.00
- Revenue This Year
- BLFS $20.32
- CDNA $13.28
- Revenue Next Year
- BLFS $19.98
- CDNA $15.13
- P/E Ratio
- BLFS N/A
- CDNA $18.95
- Revenue Growth
- BLFS 8.44
- CDNA 19.07
- 52 Week Low
- BLFS $14.84
- CDNA $7.42
- 52 Week High
- BLFS $29.55
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- BLFS 43.16
- CDNA 42.81
- Support Level
- BLFS $21.35
- CDNA $15.78
- Resistance Level
- BLFS $23.05
- CDNA $19.31
- Average True Range (ATR)
- BLFS 2.03
- CDNA 1.39
- MACD
- BLFS 0.02
- CDNA 0.14
- Stochastic Oscillator
- BLFS 42.97
- CDNA 42.30
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.